Overview of Dr. Wang
Dr. Rui Wang is an oncologist in Montvale, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Bergen, and Hackensack Meridian Health Hackensack University Medical Center. She received her medical degree from West China University of Medical Sciences and has been in practice 24 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 15 doctors at Memorial Sloan Kettering Bergen who specialize in Oncology. She has more than 20 publications and over 500 citings.
Office
225 Summit Avenue
Montvale, NJ 07645
Education & Training
West China University of Medical SciencesClass of 1996
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2015 - 2026
NJ State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Early Use of Prone Position in ECMO for Severe ARDS Start of enrollment: 2019 Nov 01
Publications & Presentations
PubMed
- 6 citationsThe GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors.Yang Qiu, Ying Li, Meng Chai, Huiming Hua, Rui Wang
Cell Death Discovery. 2023-02-04 - 3 citationsImpact of Baseline Expectancy on Outcome Prediction of Real and Sham Acupuncture for Persistent Chemotherapy-Induced Peripheral Neuropathy Pain in Solid Tumor Survivor...Xiaotong Li, Lilly Zhi, Katherine Y Han, Susan Q Li, Khalada Ahmad
Integrative Cancer Therapies. 2023-01-24 - 13 citationsHow Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR/HER2Breast Cancer in the Post-RxPONDER...Melissa Pilewskie, Varadan Sevilimedu, Idil Eroglu, Tiana Le, Rui Wang
Annals of Surgical Oncology. 2022-10-01
Press Mentions
Behind the Study: HER3: A Vital Target in Cancer TreatmentOctober 13th, 2023- New Findings in JNCCN Illustrate Pathway for Screening High-Risk Individuals for Pancreatic Cancer in PRECEDE StudyApril 17th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
